相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial OfReldesemtivIn Patients With ALS
Jeremy M. Shefner et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2021)
Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R
Leonhard A. Bakker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS)
Christina N. Fournier et al.
JAMA NEUROLOGY (2020)
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort
R. Vasta et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Current trends in the clinical trial landscape for amyotrophic lateral sclerosis
Ruben P. A. van Eijk et al.
CURRENT OPINION IN NEUROLOGY (2020)
Group sequential designs for clinical trials with bivariate endpoints
Junxiao Hu et al.
STATISTICS IN MEDICINE (2020)
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Frequent self-assessments in ALS Clinical Trials: worthwhile or an unnecessary burden for patients?
Ruben P. A. van Eijk
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Evidence for a multimodal effect of riluzole in patients with ALS?
Adriaan D. de Jongh et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
Leonard H. van den Berg et al.
NEUROLOGY (2019)
Methods for the analysis of multiple endpoints in small populations: A review
Robin Ristl et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2019)
Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale)
R. A. Smith et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
Ton Fang et al.
LANCET NEUROLOGY (2018)
TRAJECTORIES OF IMPAIRMENT IN AMYOTROPHIC LATERAL SCLEROSIS: INSIGHTS FROM THE POOLED RESOURCE OPEN-ACCESS ALS CLINICAL TRIALS COHORT
Nimish J. Thakore et al.
MUSCLE & NERVE (2018)
Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach
Nimish J. Thakore et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2018)
A New Overall-Subgroup Simultaneous Test for Optimal Inference in Biomarker-Targeted Confirmatory Trials
Ilana Belitskaya-Levy et al.
STATISTICS IN BIOSCIENCES (2018)
What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis
James Rooney et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
Richard Smith et al.
NEUROTHERAPEUTICS (2017)
Predicting functional decline and survival in amyotrophic lateral sclerosis
Mei-Lyn Ong et al.
PLOS ONE (2017)
How common are ALS plateaus and reversals?
Richard S. Bedlack et al.
NEUROLOGY (2016)
Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
Seward B. Rutkove
NEUROTHERAPEUTICS (2015)
A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements
Franco Franchignoni et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2015)
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis
Adriano Chio et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients
Hazuki Watanabe et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)
The PRO-ACT database Design, initial analyses, and predictive features
Nazem Atassi et al.
NEUROLOGY (2014)
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale
Rubika Balendra et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Evidence of multidimensionality in the ALSFRS- R Scale: a critical appraisal on its measurement properties using Rasch analysis
Franco Franchignoni et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials
James D. Berry et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
COMPARISON OF ANALYSIS APPROACHES FOR PHASE III CLINICAL TRIALS IN AMYOTROPHIC LATERAL SCLEROSIS
Brian C. Healy et al.
MUSCLE & NERVE (2012)
Through the looking glass: understanding non-inferiority
Jennifer Schumi et al.
TRIALS (2011)
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
Matthew R. Sydes et al.
TRIALS (2009)
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
F Kimura et al.
NEUROLOGY (2006)
分享论文
